Robin L. Washington
2018
In 2018, Robin L. Washington earned a total compensation of $6.3M as Former Executive Vice President, Chief Financial Officer at Gilead Sciences, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,375,421 |
|---|---|
| Option Awards | $2,000,006 |
| Salary | $1,011,750 |
| Stock Awards | $1,945,494 |
| Other | $10,000 |
| Total | $6,342,671 |
Washington received $2M in option awards, accounting for 32% of the total pay in 2018.
Washington also received $1.4M in non-equity incentive plan, $1M in salary, $1.9M in stock awards and $10K in other compensation.
Rankings
In 2018, Robin L. Washington's compensation ranked 1,449th out of 14,244 executives tracked by ExecPay. In other words, Washington earned more than 89.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,449 out of 14,244 | 90th |
Division Manufacturing | 505 out of 5,765 | 91st |
Major group Chemicals And Allied Products | 158 out of 2,128 | 93rd |
Industry group Drugs | 124 out of 1,817 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 30 out of 339 | 91st |
Source: SEC filing on March 24, 2020.
Washington's colleagues
We found three more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2018.